News AZ and Oracle team up on AI platform for clinical trials AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
Sales & Marketing A philosophical look at market turn in the Age of AI, with J... John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.
Market Access For life sciences, it’s not only about when to bring on a GC... For founders, the question is no longer just who to hire as GC, but when to hire them, and what comes next.
News Slow recruitment still hitting UK trials, says pharma Despite efforts to improve the environment for UK clinical trials, the sector is still facing headwinds like low recruitment rates and rising costs.
Sales & Marketing Revitalising life sciences hiring: The case for creative rec... The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
Patients Breaking down the challenges of donor recruitment and recall... One key aspect of the biospecimen market (if not the most important) is the availability and accessibility of the donor pool for testing of both normal, healthy donors and disease state don
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.